TNBC is a clinically aggressive and distinct breast cancer subtype, characterized by the absence or low expression of estrogen receptor (ER), progesterone receptor (PR), and HER2, as determined by IHC [4,5,31]. This evidence concerns the gene ESR1 and breast cancer.